Stewart GD - Search Results

1

A generation of laparoscopic nephrectomy: stage-specific surgical and oncologic outcomes for laparoscopic nephrectomy in a single center.

Laird A, Stewart GD, Zhong J, Ang WJ, Cutress ML, Riddick AC, McNeill SA, Tolley DA. Laird A, et al. Among authors: stewart gd. J Endourol. 2013 Aug;27(8):1008-14. doi: 10.1089/end.2012.0562. J Endourol. 2013. PMID: 23634886

2

What are the oncological risks of minimal access surgery for the treatment of urinary tract cancer?

Stewart GD, Tolley DA. Stewart GD, et al. Eur Urol. 2004 Oct;46(4):415-20. doi: 10.1016/j.eururo.2004.04.030. Eur Urol. 2004. PMID: 15363552 Review.

3

Oncological control following laparoscopic nephroureterectomy: 7-year outcome.

Bariol SV, Stewart GD, McNeill SA, Tolley DA. Bariol SV, et al. Among authors: stewart gd. J Urol. 2004 Nov;172(5 Pt 1):1805-8. doi: 10.1097/01.ju.0000140995.44338.58. J Urol. 2004. PMID: 15540724

4

A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.

Stewart GD, Bariol SV, Grigor KM, Tolley DA, McNeill SA. Stewart GD, et al. BJU Int. 2005 Apr;95(6):791-3. doi: 10.1111/j.1464-410X.2005.05402.x. BJU Int. 2005. PMID: 15794784

5

Laparoscopic suturing: effect of instrument handling on suture strength.

Bariol SV, Stewart GD, Tolley DA. Bariol SV, et al. Among authors: stewart gd. J Endourol. 2005 Nov;19(9):1127-33. doi: 10.1089/end.2005.19.1127. J Endourol. 2005. PMID: 16283852

6

Controversial cases in endourology.

Stewart GD, Bariol SV, Smith G, Moussa SA, Tolley DA. Stewart GD, et al. J Endourol. 2006 Sep;20(9):612-5. doi: 10.1089/end.2006.20.612. J Endourol. 2006. PMID: 16999609 No abstract available.

7

Results of a definitive study are needed to provide guidance on the treatment of patients with screen-detected, 'low-grade' prostate cancer.

Stewart GD, Riddick AC, Bollina PR, McNeill SA. Stewart GD, et al. BJU Int. 2006 Nov;98(5):944-5. doi: 10.1111/j.1464-410X.2006.06540.x. BJU Int. 2006. PMID: 17034595 No abstract available.

8

Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.

Stewart GD, Lowrie AG, Riddick AC, Fearon KC, Habib FK, Ross JA. Stewart GD, et al. Prostate. 2007 Sep 1;67(12):1308-17. doi: 10.1002/pros.20618. Prostate. 2007. PMID: 17626247

9

NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.

Stewart GD, Nanda J, Brown DJ, Riddick AC, Ross JA, Habib FK. Stewart GD, et al. Int J Cancer. 2009 Jan 1;124(1):223-32. doi: 10.1002/ijc.23934. Int J Cancer. 2009. PMID: 18924134

10

Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score.

Stewart GD, Gray K, Pennington CJ, Edwards DR, Riddick AC, Ross JA, Habib FK. Stewart GD, et al. Oncol Rep. 2008 Dec;20(6):1561-7. Oncol Rep. 2008. PMID: 19020742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters